Premium

The company also retains aRoyaltyinterest in BHP'sMiningArea C iron ore operations, which provides a steady,Capital-light cash stream that has historically helped fund counter-cyclicalInvestment. This combination - established mineral sands, an iron ore royalty, and an emerging rare earthsBusiness- makes Iluka one of the more …

Metcash Ltd (ASX:MTS) is the largest wholesale supplier to independent retailers across Australia. Its operations span three pillars: Food, primarily theSupplyof IGA and other independent supermarkets; Liquor, which supports the Cellarbrations, IGA Liquor and other independent banner networks; and Hardware, which encompasses Mitre 10, …

Bega Cheese Limited (ASX:BGA) has attracted renewed investor attention following the release of its first-half FY2026 financial results and an upward revision to full-year earnings guidance. The Australian dairy and food company reported notable growth across profitability metrics while continuing to execute operational improvement …

Few companies on the Australian Securities Exchange have generated as much investor attention over the past year as 4DMedical Limited (ASX:4DX). The healthcare technology company has delivered a remarkable share price performance, rising more than 1,100% over the past twelve months as investors increasingly …

Abacus Storage King (ASX:ASK) is entering one of the most significant transitions in its corporate history. The self-storage real estateInvestmenttrust has announced plans to internalise management functions, a move that will coincide with a rebranding to Storage King Group and a new ASX ticker, …

DigiCo Infrastructure REIT (ASX:DGT) has entered a significant new phase of its growth strategy following the announcement of a major asset sale and a substantial reduction inDebt. The data centre-focused real estateInvestmenttrust has agreed to sell its Chicago data centre asset while redirectingCapitaltoward expansion …

Pro Medicus Limited (ASX:PME) remains one of Australia's most closely followed healthcare technology companies. Despite delivering another period of revenue growth, expanding profitability, and securing multiple major healthcare contracts in North America, the stock remains more than 43% below levels seen a year ago.